Eli Lilly (LLY) r&d spend was $13.3B in FY2025 (+21% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$13.3B
+21%
2024
$11.0B
+18%
2023
$9.3B
+30%
2022
$7.2B
+4%
2021
$6.9B
+16%
2020
$6.0B
+7%
2019
$5.6B
+11%
2018
$5.1B
-1%
2017
$5.1B
-4%
2016
$5.3B
+11%
2015
$4.8B
+1%
2014
$4.7B
-14%
2013
$5.5B
+5%
2012
$5.3B
+5%
2011
$5.0B
+3%
2010
$4.9B
+13%
2009
$4.3B
+13%
2008
$3.8B
+10%
2007
$3.5B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q1 2026
$3.5B
Q4 2025
$3.8B
Q3 2025
$3.5B
Q2 2025
$3.3B
Q1 2025
$2.7B
Q4 2024
$3.0B
Q3 2024
$2.7B
Q2 2024
$2.7B
Q1 2024
$2.5B
Q4 2023
$2.6B
Q3 2023
$2.4B
Q2 2023
$2.4B
Source: LLY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.